PubMed ID:
18042575
Public Release Type:
Journal
Publication Year: 2007
Affiliation: Division of Gastroenterology and Nutrition, Department of Pediatrics, University of Washington, Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA. Karen.murray@seattlechildrens.org
DOI:
https://doi.org/10.1177/1740774507085445
Authors:
Barton BA,
González-Peralta RP,
Murray KF,
PEDS-C Clinical Research Network,
Robuck PR,
Rodrigue JR,
Schwarz KB,
Shepherd J
Studies:
Pegylated Interferon +/- Ribavirin for Children with HCV
PEDS-C is the first multicenter placebo-controlled trial for the treatment of chronic hepatitis C (HCV) in childhood that has ever been conducted in the United States (USA). Establishment of the research team, protocol, administrative infrastructure, and ancillary contributors for the pediatric trial took years of planning.